Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication,
belonging to the group of incretin mimetics, approved in April 2005 for the
Jun 15, 2016 ... Exenatide injection may increase the risk that you will develop tumors of the
thyroid gland, including medullary thyroid carcinoma (MTC; a type ...
Dec 19, 2014 ... DRUG CLASS AND MECHANISM: Exenatide is an injectable drug that reduces
the level of sugar (glucose) in the blood. It is used for treating ...
Learn about BYDUREON® (exenatide extended-release for injectable
suspension), a non-insulin treatment option for adults with type 2 diabetes
available in the ...
Exenatide is an antidiabetic injection that is used in treating type 2 diabetes.
Read more about diabetes treatments and antidiabetic injections at Patient.
May 16, 2007 ... Description, Exenatide, derived from a compound found in the saliva of the Gila
monster, a large lizard native to the southwestern US, is a ...
Exenatide is the first drug in the incretin mimetic class and is indicated for
treatment of type 2 diabetes mellitus. Although structurally similar to the native ...
Drug Name · Active Ingredients · BYDUREON, EXENATIDE SYNTHETIC.
BYDUREON PEN, EXENATIDE SYNTHETIC. BYETTA, EXENATIDE SYNTHETIC
Byetta (exenatide) is approved as an adjunct to diet and exercise to improve
glycemic control in adults with type 2 diabetes mellitus. Adverse reactions or
Byetta (exenatide): For the adjunctive treatment of Type 2 diabetes mellitus. New
approved drug details including side effects, uses and general information.